Hip Replacement Implants Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The hip replacement implants market encompasses a range of products including femoral stems, acetabular cups, liners, bearings, and complete hip systems used in total and partial hip arthroplasty procedures. Valued at approximately $23.37 billion globally in 2025, the sector forms a significant portion of the broader orthopedic implant industry, which is projected to reach $79.5 billion by 2030. Procedural volume for primary total hip arthroplasty is expected to rise substantially through 2030, supported by demographic trends and improvements in surgical technique and implant durability.

• •Total joint replacement market valued at ~$22.5 billion in 2024 with a 4% CAGR trajectory
• •Primary total hip arthroplasty procedures projected to increase significantly through 2030
• •Hip implants represent a leading segment within the broader orthopedic reconstruction market

Population aging is the dominant macro driver, as age remains the strongest risk factor for osteoarthritis and hip joint degeneration. Rising prevalence of hip fractures due to osteoporosis, expanding healthcare access in developing regions, and growing patient awareness of surgical treatment options further contribute to rising demand. Concurrently, advances in implant materials and surgical precision are encouraging earlier intervention and expanding the pool of eligible patients.

• •Elderly population growth fueling increased incidence of osteoarthritis and degenerative joint disease
• •Improvements in implant biocompatibility and wear resistance extending device lifespan and patient candidacy
• •Expansion of healthcare infrastructure and reimbursement coverage in emerging markets broadening access

The market is segmented by product type, including cemented, cementless, and hybrid fixation systems, as well as by procedure type (primary vs. revision hip arthroplasty) and material (metal-on-polyethylene, ceramic-on-ceramic, metal-on-metal). Geographically, North America and Europe dominate due to high procedural volumes, established healthcare systems, and early adoption of advanced technologies. Asia-Pacific is the fastest-growing region, driven by aging populations in China and Japan and improving surgical access across Southeast Asia and India.

• •North America leads in market share, supported by high obesity rates and advanced healthcare infrastructure
• •Asia-Pacific emerging as the fastest-growing region with rising orthopedic surgery adoption
• •Cementless fixation systems gaining share due to improved osseointegration and longer implant survivorship

What are the recent trends and outlook?

Emerging technologies are reshaping the competitive and clinical landscape, with additive manufacturing enabling patient-specific implants and porous structures that promote bone ingrowth. Artificial intelligence is increasingly integrated into pre-operative planning tools to improve surgical accuracy and implant positioning. Minimally invasive surgical approaches and robotic-assisted surgery are gaining adoption, while sustained investment in surface crosslinking and advanced ceramic materials aims to further reduce wear debris and extend implant longevity. The market is expected to maintain its 4% CAGR trajectory through the decade, reaching approximately $28.7 billion as procedural volumes and product pricing evolve.

• •3D-printed and patient-specific implants gaining clinical traction for complex anatomical cases
• •Robotic-assisted surgery and AI-powered planning tools improving surgical precision and outcomes
• •Next-generation bearing surfaces and surface crosslinking technologies targeting reduced revision rates